The Promise of Janus Kinase Inhibitors
In this Derm Discussions, Brett King, MD, PhD, joins Brad Glick, DO, to discuss the potential of the JAK inhibitor class for dermatology.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.